{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q08117",
      "entity_text" : "AEs",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P02774",
      "entity_text" : "GC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "However, consistent with other analyses, we found that an increase in the oral GC dose increases the risk of several glucocorticoid related AEs [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-07-28T17:45:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:43:34Z",
  "trigger" : "increases",
  "evidence" : [ "GC dose increases the risk of several glucocorticoid-related AEs" ],
  "pmc_id" : "6858477",
  "score" : 0
}